Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 6, 2000, Pages 1844-1849

  Fukuyama, Satoru ^a,b   Inoue, Hiromasa ^a,b   Aizawa, Hisamichi ^a,b,c,e   Oike, Masahiro ^a,b   Kitaura, Motoji ^a,b   Yoshie, Osamu ^a,b,d   Hara, Nobuyuki ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EOTAXIN; HISTAMINE; INTERLEUKIN 5; LEUKOTRIENE D4; PEROXIDASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CALCIUM CELL LEVEL; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHILIA; GUINEA PIG; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034048053     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.6.9905039     Document Type: Article

References (35)

1. 1. Bousquet. J., P. Chanez, J. Y. Lacoste, I. Enander, P. Venge, C. Peterson, S. Ahlstedt, F. B. Michel, and P. Godard. 1991. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J. Allergy Clin. Immunol. 88:649-660.
2. 2. Poston, R. N., P. Chanez, J. Y. Lacoste, T. Litchfield, T. H. Lee, and J. Bousquet. 1992. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am. Rev. Respir. Dis. 145:918-921.
3. 3. Barnes, P. J. 1994. Cytokines as mediators of chronic asthma. Am. J. Respir. Crit. Care Med. 150:S42-S49.
4. 4. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179: 881-887.
5. 5. Jose, P. J., I. M. Adcock, D. A. Griffiths-Johnson, N. Berkman, T. N. Wells, T. J. Williams, and C. A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. 205:788-794.
6. 6. Rothenberg, M. E., A. D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. U.S.A. 92: 8960-8964.
7. 7. Ponath, P. D., S. Qin, D. J. Ringler, I. dark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. A. Gonzalo, W. Newman, J. C. Gutierrez-Ramos, and C. R. Mackay. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
8. 8. Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, P. M. Murphy, and O. Yoshie. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271:7725-7730.
9. 9. Griffiths-Johnson, D. A., P. D. Collins, A. G. Rossi, P. J. Jose, and T. J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197:1167-1172.
10. 10. Teixeira, M. M., T. N. Wells, N. W. Lukacs, A. E. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657-1666.
11. 11. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, J. D. Griffiths, T. J. Williams, and P. J. Jose. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
12. 12. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
13. 13. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp. Med. 183:2437-2448.
14. 14. Mattoli, S., M. A. Stacey, G. Sun, A. Bellini, and M. Marini. 1997. Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. 236:299-301.
15. 15. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepeda, M. E. Rothenberg. J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767-1773.
16. 16. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. 2:449-456.
17. 17. Matsumoto, K., H. Aizawa, H. Inoue, H. Koto, S. Takata, M. Shigyo, H. Nakano, and N. Hara. 1998. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. Eur. Respir. J. 12:387-394.
18. 18. Louis, R., D. Degroote, T. Bury, J. L. Corhay, J. M. Kayembe, P. Franchimont, and M. F. Radermecker. 1995. Changes in bronchial responsiveness, circulating leucocytes and ex vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics. Eur. Respir. J. 8:611-618.
19. 19. Yamaguchi, S., H. Nagai, H. Tanaka, M. Tsujimoto, and N. Tsuruoka. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 54:471-475.
20. 20. Ohkawara, Y., X. F. Lei, M. R. Stampfli, J. S. Marshall, Z. Xing, and M. Jordana. 1997. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am. J. Respir. Cell Mol. Biol. 16:510-520.
21. 4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am. J. Respir. Crit. Care Med. 154:850-857.
22. 22. Matsumoto, K., H. Aizawa, H. Inoue, M. Shigyo, S. Takata, and N. Hara. 1996. Thromboxane causes airway hyperresponsiveness after cigarette smoke-induced neurogenic inflammation. J. Appl. Physiol. 81:2358-2364.
23. 23. Kraneveld, A. D., F. P. Nijkamp, and O. A. Van. 1997. Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. Am. J. Respir. Crit. Care Med. 156:367-374.
24. 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology 73: 222-227.
25. 25. Frevert, C. W., V. A. Wong, R. B. Goodman, R. Goodwin, and T. R. Martin. 1998. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods. 213:41-52.
26. 26. Okada, S., H. Kita, T. J. George, G. J. Gleich, and K. M. Leiferman. 1997. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am. J. Respir. Cell Mol. Biol. 16:455-463.
27. 27. Barnes, P. J., K. F. Chung, and C. P. Page. 1988. Platelet-activating factor as a mediator of allergic disease. J. Allergy Clin. Immunol. 81:919-934.
28. 28. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
29. 29. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182: 1169-1174.
30. 4. Proc. Natl. Acad. Sci. U.S.A. 80:1712-1716.
31. 31. Griffin, M., J. W. Weiss, A. G. Leitch, E. J. McFadden, E. J. Corey, K. F. Austen, and J. M. Drazen. 1983. Effects of leukotriene D on the airways in asthma. N. Engl. J. Med. 308:436-439.
32. 4. and histamine in normal human subjects. Thorax 39:500-504.
33. 33. Cuss, F. M., C. M. Dixon, and P. J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2:189-192.
34. 34. Rubin, A. H., L. J. Smith, and R. Patterson. 1987. The bronchoconstrictor properties of platelet-activating factor in humans. Am. Rev. Respir. Dis. 136:1145-1151.
35. 35. Hozawa, S., Y. Haruta, S. Ishioka, and M. Yamakido. 1995. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198-1202.